Massachusetts continues to lean on a network of state financing and development programs, anchored by the Massachusetts Development Finance Agency (MassDevelopment), to support business growth, infrastructure, and job creation across the Commonwealth. MassDevelopment, the state’s quasi-public economic development agency, provides financing, real estate development, and technical assistance to businesses, nonprofits, and municipalities, and continues to serve as one of the state’s primary tools for supporting projects that traditional lenders may not fully finance on their own.

State officials have continued to frame long-term economic competitiveness as a priority through 2026, with the Healey-Driscoll administration’s economic development initiatives emphasizing what state materials describe as “powering a high-growth economy” — language used in state economic development communications to describe efforts spanning workforce development, infrastructure, and support for key industries such as life sciences, clean energy, and advanced manufacturing.

MassDevelopment’s role includes both direct financing — such as bonds and loans for qualifying projects — and support for small businesses navigating financing gaps, an area the agency has continued to highlight in outreach and educational programming aimed at smaller Massachusetts employers throughout 2026. That small-business-facing work sits alongside the agency’s larger real estate and infrastructure development projects across the state.

Beyond MassDevelopment, the state legislature has continued to consider broader economic development legislation, with the Governor’s office filing economic development bills aimed at addressing competitiveness concerns raised by business groups such as the Massachusetts Taxpayers Foundation and the Massachusetts Municipal Association. These groups have continued to weigh in on the state’s approach to taxation, permitting, and infrastructure investment as components of the Commonwealth’s broader competitiveness.

For Boston-area businesses, the practical effect of these state-level tools is most visible in specific financed projects — from small-business loans to larger real estate developments — that collectively shape the pace and geography of growth across Greater Boston and the rest of the Commonwealth.

Sources:

• https://www.mass.gov/info-details/powering-a-high-growth-economy
• https://en.wikipedia.org/wiki/Massachusetts_Development_Finance_Agency
• https://www.mma.org/gov-files-economic-development-bill/
• https://www.masstaxpayers.org/taxonomy/term/35

Background

Many states use public or quasi-public agencies to support economic development. A quasi-public agency is created by state law and serves a public purpose, but it operates with more independence than a typical government department, often with its own board and its own sources of revenue. These agencies can fill roles that neither ordinary government offices nor private lenders handle easily on their own.

One common tool is bond financing. Certain projects, such as facilities for qualifying nonprofits or some manufacturing projects, may be eligible for tax-exempt bonds. In many such cases, a state agency acts as a conduit issuer: it issues the bonds on behalf of the borrower, and the borrower is responsible for repaying them. Because interest on qualifying bonds is generally exempt from federal income tax, borrowers may be able to obtain lower interest rates than they could with taxable financing.

Another role is gap financing. A project may be viable but unable to secure all of its funding from traditional lenders, perhaps because of its location, its size or the risk lenders perceive. A development agency may provide loans, guarantees or other support that helps close the remaining gap, often alongside private lenders rather than replacing them.

What it means for small businesses

For small business owners, state development programs are one part of a broader set of resources. A few general steps help any business explore its options:

• Start with your current lender. Banks and credit unions can often explain whether a project might fit a state or federal program, and some work regularly with development agencies.
• Use free counseling. Small Business Development Centers and SCORE mentors can help prepare financial statements and loan applications.
• Consider community lenders. Community development financial institutions focus on borrowers and areas that may be underserved by traditional banks.
• Learn federal programs too. The U.S. Small Business Administration guarantees certain loans made by participating lenders.
• Prepare documentation. Clear business plans, financial statements and project budgets make it easier for any lender or agency to evaluate a request.
• Ask about timelines. Public financing can involve applications, reviews and approvals that take longer than a conventional loan.

Key terms

• Quasi-public agency: A body created by law to serve a public purpose, operating with some independence from regular government departments.
• Conduit issuer: An agency that issues bonds on behalf of a borrower, which is responsible for repayment.
• Tax-exempt bond: A bond whose interest is generally not subject to federal income tax, available only for qualifying purposes.
• Gap financing: Funding that covers the difference between a project’s cost and what other sources will provide.
• Technical assistance: Advice, planning help or training provided to businesses, nonprofits or municipalities.
• Economic development bill: Legislation that sets policy and often authorizes spending or borrowing for programs supporting business growth and infrastructure.

What to watch

Several public sources can help Boston-area businesses follow developments, without assuming any particular outcome:

• The progress of economic development legislation through the Legislature, including committee hearings and votes.
• Program announcements and application windows from state agencies.
• Published lists of financed projects, which show where and how state tools are being used.
• Reports and testimony from business groups, municipal associations and research organizations.
• Local planning and permitting decisions that affect specific projects in your community.

Boston built its reputation as an innovation hub on a simple formula: world-class research institutions feeding a steady pipeline of venture-backed startups, especially in biotech. That formula is under more pressure than it’s faced in years.

Fewer companies are getting funded

Massachusetts’ share of national venture capital dollars has slipped, and the number of companies in the state receiving funding has fallen by 13%. For a regional economy where early-stage funding rounds often determine whether a lab-based startup can hire its next ten employees, that decline matters well beyond the venture world itself.

Empty lab space tells the same story

Much of the lab and life-sciences real estate built during the pandemic-era expansion now sits vacant at record levels. Developers who bet heavily on continued biotech growth in Cambridge, the Seaport, and along Route 128 are now absorbing that space more slowly than projected, which in turn has made landlords and lenders more cautious about financing the next wave of lab construction.

Layoffs compound the funding slowdown

The funding pullback is landing at the same time hiring in the sector has turned negative: 745 life sciences jobs were cut across 14 Massachusetts companies in the first quarter of 2026 alone. Fewer new funding rounds and fewer open positions together make it harder for laid-off scientists and executives to find their next role without leaving the state entirely — a dynamic that feeds directly into the broader population and talent-retention concerns policymakers have been raising this year.

The state’s response

Governor Healey’s $4 billion Mass Leads Act is designed specifically to shore up life sciences and technology, and the state’s new Competitiveness Council has been tasked with identifying regulatory and tax changes that could make Massachusetts more attractive to venture investors and the companies they fund. More than 30 companies have expanded in the state recently, evidence that the ecosystem hasn’t stalled entirely — but the funding and real estate data both point to a market that has cooled meaningfully from its pandemic-era highs.

What it means for founders and workers

For entrepreneurs building in Boston right now, the practical takeaway is that capital is more selective and runways matter more than they did two or three years ago. Boston Made’s Economy desk will continue tracking funding, lab vacancy, and hiring data across the innovation sector as it develops.

Background

Massachusetts’ innovation economy grew around a set of reinforcing strengths: research universities that produce discoveries and graduates, teaching hospitals that run clinical research, and investors willing to fund early-stage companies. Biotech in particular depends on long timelines. A drug can take many years to move from the lab through clinical trials to approval, and most candidates do not succeed. Venture capital fills the gap by funding companies through those years in exchange for ownership.

Lab space is a distinctive part of the picture. Life sciences buildings need specialized ventilation, plumbing, power and safety features, which makes them more expensive to build than ordinary offices and harder to convert to other uses. When demand for lab space falls, those buildings can remain vacant longer than general office space might.

How venture funding works

Startups typically raise money in stages. Early rounds fund research and prototypes. Later rounds fund larger trials, hiring and commercialization. Each round is priced based on the company’s progress and investors’ view of its prospects. When investors become more cautious, companies may find it harder to raise new money, may raise at lower valuations or may cut costs to extend the time their existing funds will last.

• Seed and Series A: early funding for initial research and team building.
• Later rounds: larger amounts for clinical trials, scale-up or market entry.
• Bridge funding: smaller amounts to carry a company to its next milestone.
• Exits: acquisitions or public offerings that return money to investors.

What it means for founders and workers

For founders, a more selective funding environment usually rewards clear milestones, careful spending and realistic plans. For workers, it can mean fewer openings and more competition for roles, but also opportunities at companies that are still growing. Professional networks, industry associations and university career resources can help people navigate a slower market.

• Track runway carefully and plan for funding to take longer than expected.
• Keep relationships with investors active even between fundraising rounds.
• Explore grants and nondilutive funding sources where available.
• For job seekers, consider adjacent roles that use similar skills.

Key terms

• Venture capital: investment in young, high-growth companies in exchange for equity.
• Runway: how long a company can operate before it runs out of cash.
• Lab vacancy: the share of laboratory space that is unoccupied.
• Nondilutive funding: money, such as grants, that does not require giving up ownership.
• Valuation: the value assigned to a company in a funding round.
• Life sciences: fields including biotechnology, pharmaceuticals and medical devices.

What to watch

• Quarterly venture funding reports for Massachusetts and national comparisons.
• Lab vacancy and leasing trends in Cambridge, the Seaport and suburban markets.
• Hiring and layoff announcements in the life sciences sector.
• Implementation of the Mass Leads Act and recommendations from the Competitiveness Council.
• Company expansions and relocations into or out of the state.

Funding data is often reported by quarter, and a single very large round can lift a total sharply, so looking at the number of deals alongside the dollar amount gives a clearer sense of how broadly capital is reaching companies across the ecosystem.

For a state built on world-class hospitals, universities, and a biotech cluster that draws talent from around the globe, 2026 has brought an uncomfortable question: is the Massachusetts economic model starting to crack?

People and companies are leaving

Massachusetts lost 33,340 net residents in the year ending July 2025, with young adults leading the departures. The exits haven’t been limited to individuals. SynQor relocated with roughly 250 jobs, Analogic moved about 500 positions out of state, and both Zipcar and Panera have shifted operations elsewhere. In January 2026 alone, ten companies eliminated a combined 905 jobs. The state is now one of only four in the country with fewer private-sector jobs than it had before the pandemic — a shortfall of roughly 24,000 jobs since January 2020.

Three pillars, all under strain at once

What makes this moment different from past slowdowns is that higher education, health care, and biotech — the three industries that have anchored the state’s economy for a generation — are all showing stress simultaneously.

Higher education: Twelve Massachusetts colleges have closed or merged over the past decade. UMass Chan Medical School’s PhD admissions fell from 73 students to just 13 in a single year, and Harvard is cutting its science PhD enrollment roughly in half.

Health care: Only six of the state’s nearly two dozen hospital systems turned a profit last year. Mass General Brigham has been managing a $250 million budget gap, while UMass Memorial lost $86 million in the first half of fiscal 2025 alone.

Biotech: Venture capital’s share of funding to Massachusetts life sciences companies has declined, the number of funded companies has dropped by 13%, and lab space built during the pandemic-era boom now sits vacant at record levels — a backdrop to the 745 biotech layoffs recorded in the first quarter of 2026 alone.

Federal policy adds pressure

Boston University economist Mark Williams has estimated that tariffs alone could eliminate nearly 80,000 Massachusetts jobs and cost the state $1 billion in tax revenue. State officials have also flagged federal funding being redirected toward other states, along with a proposed $424 million in Medicaid cuts that would hit Massachusetts hospitals directly.

The cost-of-living squeeze

Housing remains the biggest single driver of people leaving the state, compounding the pressure on employers trying to hire. A four-year degree at a private Massachusetts university now commonly exceeds $400,000 all-in, and the state has the third-highest electricity rates in the country — both of which show up in household budgets long before they show up in state economic data.

What the state is doing about it

Governor Maura Healey’s administration has rolled out a $4 billion Mass Leads Act aimed at the life sciences and technology sectors, a $400 million DRIVE Initiative, and a new Competitiveness Council, while pointing to more than 30 companies that have recently expanded in the state. House Ways and Means Chair Aaron Michlewitz has highlighted resilience in state revenue numbers as a counterpoint to the more alarming headlines.

Those efforts have run into resistance, though: a broader tax-cut package was significantly scaled back, new revenue-raising proposals didn’t survive the legislative process, and a commercial property tax proposal from Boston Mayor Michelle Wu was rejected in the Senate.

Where this leaves Massachusetts

None of this means the state’s economy is collapsing — job growth is still outpacing the national average on a monthly basis, and the “millionaires tax” continues to generate billions more than originally projected, evidence that high earners aren’t fleeing en masse. But the simultaneous strain across education, health care, and biotech, layered on top of a real (if modest) population decline, is a meaningfully different economic story than the one Massachusetts told about itself for most of the past two decades. Boston Made’s Economy desk will keep following each of these threads as new data comes in.